A Simple And Rapid Method For Detection Of Bluetongue Virus In Cell Culture Using Rt-Pcr by Tajelsir, Afra'a
 
A SIMPLE AND RAPID METHOD FOR DETECTION 
OF BLUETONGUE VIRUS IN CELL CULTURE 
USING RT-PCR 
 
 
 
 
  
By 
 
Afra'a Tajelsir Mohamed Elata 
  
B.V.M, University of Khartoum, 2002 
 
 
 
 
 
 
 
A thesis submitted to the University of Khartoum in fulfillment of the 
requirements for the Master degree in Veterinary Medicine 
 
 
 
 
 
Supervisor:  
Prof. Imadeldin Elamin Eltahir Aradaib 
  
Department of Medicine, Pharmacology and Toxicology 
Faculty of Veterinary Medicine 
University of Khartoum   
 
 
April, 2007  
 i
  
 
DEDICATION 
 
 
TO THE SOUL OF MY FATHER ….. 
 
TO MY MOTHER ….. 
 
TO MY BROTHERS AND SISTERS ….. 
 
 
 
 
WITH ALL MY LOVE  
 
 
 
 
 ii
Acknowledgements 
 
My gratitude and special thanks to Prof. Imadeldin 
Elamin Eltahir Aradaib, Molecular Biology Laboratory, 
Department of Medicine, Pharmacology and Toxicology, 
Faculty of Veterinary Medicine, University of Khartoum, my 
supervisor, for his encouragement, full assistance and 
support during the completion of this work. It has been a 
privilege and a unique opportunity to work under his 
supervision. His suggestions and advices were of great value. 
So, I am very indebted to him for his keen interest and 
enthusiasm.  
I would like to thank my colleagues at the Molecular 
Biology Laboratory, namely; Dr. Khairalla Mohamed Saeed, 
Ahmed Osman, Imadeldeen Osman, Samah Abdelrahman, 
Amel Mahmoud and Tumadur Mohamed for their thorough 
and unlimited support and comments. 
Thanks are extended to my colleagues at the 
Department of Medicine, Pharmacology and Toxicology for 
their help and continuous assistance during my work in this 
research.    
 iii
Last, but not least, I must express my gratitude to my 
friends, especially Hanan, Rasha, Ranya, Reem, Siham and 
Ahmed Omer for being close to me during the hard time of my 
work, and for their great help and continuous encouragement. 
I am very lucky to have kind friends such like them.  
 For all of those people, I send my appreciation and 
respect.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iv
LIST OF CONTENTS 
 
  Page 
 Dedication……………………………………….. i 
 Acknowledgements……………………………… ii 
 List of contents…………………………………... iv 
 List of Figures…………………………………… vi 
 Abstract………………………………………….. vii 
 Arabic abstract………………………………….. ix 
CHAPTER ONE: INTRODUCTION AND GENERAL 
LITERATURE    REVIEW 
 
1.1 Introduction……………………………………... 1 
1.2 The bluetongue virus……………………………. 3 
1.2.1 Virus classification……………………………… 3 
1.2.2 Virus structure…………………………………... 4 
1.3 Vector and Transmission……………………….. 5 
1.4 Epidemiology and Distribution………………… 8 
1.5 Bluetongue disease in Sudan…………………… 10 
1.6 Economic Importance…………………………... 11 
1.7 Pathology of bluetongue disease………………... 12 
1.7.1 Pathogenesis of BTV……………………………. 12 
1.7.2  Immune response to bluetongue virus…………. 13 
1.7.3 Clinical signs…………………………………….. 14 
1.7.4 Post-mortem findings…………………………… 16 
1.8 Diagnosis of BTV………………………………... 17 
1.8.1 Virus Isolation…………………………………... 17 
1.8.1.1 Embryonated Chicken Eggs (ECE)……………. 18 
1.8.1.2 Sheep inoculation………………………………... 19 
1.8.1.3 Cultured cells……………………………………. 19 
 v
1.8.2 Virus Identification……………………………... 20 
1.8.2.1 Serological techniques…………………………... 20 
1.8.2.1.1 Agar gel immunodiffusion (AGID)…………….. 21 
1.8.2.1.2  Competitive enzyme-linked      
 Immuno sorbent assay (c-ELISA)……………… 
 
21 
1.8.2.2 Virological techniques…………………………... 22 
1.8.2.2.1 Virus neutralization test 22 
1.8.2.3 Reverse transcriptase-polymerase chain  
reaction (RT-PCR)……………………………… 
 
22 
1.9 Prevention and control 23 
CHAPTER TWO: MATERIALS AND METHODS    
2.1  Bluetongue virus………………………………... 27 
2.2 Virus propagation in tissue culture……………. 27 
2.3 Viral nucleic acid extraction from  infected cell 
monolayers………………………......................... 
 
28 
2.4  Primers selection……………………………….. 29 
2.5  Reverse transcriptase polymerase            chain 
reaction (RT-PCR)……………………………… 
 
30 
2.6 Agarose gel electrophoresis…………………….. 31 
CHAPTER THREE: RESULTS………………………………… 36 
CHAPTER FOUR: DISCUSSION……………………………… 40 
REFFERENCES…………………………………………………. 46 
 
              
                                      
 
 
 
 
 
                                                                                           
 
 vi
 
LIST OF FIGURES 
 
Figure 2.1: Thermal cycler TECHNE, TC-41……………………………… 33 
Figure 2.2: Electrophoresis apparatus……………………………………… 34 
Figure 2.3: Gel documentation apparatus………………………………….. 35 
Figure 3.1: Detection of BTV serotypes in infected cell cultures…………. 37 
Figure 3.2: Specificity of RT-PCR for BTV………………………………... 38 
Figure 3.3: Sensitivity of RT-PCR for BTV………………………………... 39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii
ABSTRACT 
 
In this study, a reverse transcriptase polymerase chain reaction 
(RT-PCR) protocol was evaluated for detection of bluetongue virus 
(BTV) RNA in cell culture. 
North American BTV serotypes 2, 10, 11, and 13, and Sudanese 
BTV serotype 2 were studied. All these serotypes were propagated in cell 
culture. RNAs were extracted from these serotypes and then, they were 
detected by the described RT-PCR assay, using primers derived from 
segment 6 of BTV-17 which codes for non-structural protein 1 (NS1). So, 
this NS1 gene was targeted for PCR amplification. 
The specific 614 bp PCR product was amplified from all BTV 
serotypes used in the study and they were visualized on ethidium 
bromide-stained agarose gel.  
Amplification product was not detected when the RT-PCR assay 
was applied to RNA from epizootic hemorrhagic disease virus (EHDV) 
or Palyam virus.  
Also this specific 614 bp PCR product was obtained from the 
amounts of 1ng, 500pg, 250pg and 125pg RNA from Sudanese BTV 
serotype 2.  
 viii
The results of this study indicated that the described RT-PCR 
assay, using the mentioned primers, could be applied for detection of 
BTV serogroups. 
In conclusion, the described RT-PCR assay could be used as a 
simple, rapid, sensitive and specific supportive diagnostic assay to the 
current conventional procedures used for detection of BTV.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xi 
 ﻣﻠﺨﺺ اﻷﻃﺮوﺣﺔ
 
 ﻓﻲ ﺍﻟﻜﺸﻑ ﻋﻥ ﺍﻟﺤﻤﺽ ﺍﻟﻨﻭﻭﻱ ﻡ ﺘﻔﺎﻋل ﺍﻟﺒﻠﻤﺭﺓ ﺍﻟﻤﺘﺴﻠﺴل ﺍﻟﻌﻜﺴﻲﻓﻲ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺘﻡ ﺘﻘﻴﻴ
  . ﺍﻟﺭﻴﺒﻲ ﻟﻔﻴﺭﻭﺱ ﺍﻟﻠﺴﺎﻥ ﺍﻷﺯﺭﻕ ﻤﻥ ﺍﻟﺯﺭﻉ ﺍﻟﺨﻠﻭﻱ
ﻟﻤﺘﻭﻁﻨﺔ ﻓﻲ ﺃﻤﺭﻴﻜﺎ  ﺍ31 ﻭ 11, 01, 2ﺘﻤﺕ ﺩﺭﺍﺴﺔ ﺍﻷﻨﻤﺎﻁ ﺍﻟﻤﺼﻠﻴﺔ ﻟﻔﻴﺭﻭﺱ ﺍﻟﻠﺴﺎﻥ ﺍﻷﺯﺭﻕ 
ﺜﺎﺭﻫﺎ ﻓﻲ ﻜل ﻫﺫﻩ ﺍﻷﻨﻤﺎﻁ ﺍﻟﻤﺼﻠﻴﺔ ﺘﻡ ﺇﻜ. ﻓﻲ ﺍﻟﺴﻭﺩﺍﻥ  ﺍﻟﻤﺘﻭﻁﻥ2ﺍﻟﺸﻤﺎﻟﻴﺔ ﻭ ﺍﻟﻨﻤﻁ ﺍﻟﻤﺼﻠﻲ  
 ﺍﻟﻜﺸﻑ ﻋﻨﻪ ﺒﻭﺍﺴﻁﺔ  ﺘﻡﻭ ﻤﻥ ﺜﻡ, ﺹ ﺍﻟﺤﻤﺽ ﺍﻟﻨﻭﻭﻱ ﺍﻟﺭﻴﺒﻲ ﻤﻨﻬﺎﺍﻟﺯﺭﻉ ﺍﻟﺨﻠﻭﻱ ﻭ ﺍﺴﺘﺨﻠ
 ﻤﻥ ﺠﻴﻨﻭﻡ ﺍﻟﻨﻤﻁ ﺍﻟﻤﺼﻠﻲ 6ﺘﻔﺎﻋل ﺍﻟﺒﻠﻤﺭﺓ ﺍﻟﻤﺘﺴﻠﺴل ﺒﺎﺴﺘﺨﺩﺍﻡ ﺒﺎﺩﺌﺎﺕ ﻤﺸﺘﻘﺔ ﻤﻥ ﺍﻟﻘﻁﻌﺔ ﺭﻗﻡ 
  .  ﻟﻠﻔﻴﺭﻭﺱ1ﺘﻴﻥ ﻏﻴﺭ ﺍﻟﺘﺭﻜﻴﺒﻲ ﺭﻗﻡ  ﻟﻔﻴﺭﻭﺱ ﺍﻟﻠﺴﺎﻥ ﺍﻷﺯﺭﻕ ﻭ ﺍﻟﺘﻲ ﺘﺸﻔﺭ ﻹﻨﺘﺎﺝ ﺍﻟﺒﺭﻭ71
 ﺯﻭﺝ ﻗﺎﻋﺩﻱ ﺘﻡ ﺇﻜﺜﺎﺭﻩ ﻤﻥ ﺠﻤﻴﻊ ﺍﻷﻨﻤﺎﻁ 416ﻨﺎﺘﺞ ﺘﻔﺎﻋل ﺍﻟﺒﻠﻤﺭﺓ ﺍﻟﻤﺘﺴﻠﺴل ﺍﻟﺒﺎﻟﻎ ﻁﻭﻟﻪ 
ﻭ ﺘﻡ ﺇﻅﻬﺎﺭﻩ ﻓﻲ ﻫﻼﻡ ﺍﻟﺠل , ﺍﻟﻤﺼﻠﻴﺔ ﻟﻔﻴﺭﻭﺱ ﺍﻟﻠﺴﺎﻥ ﺍﻷﺯﺭﻕ ﺍﻟﻤﺴﺘﺨﺩﻤﺔ ﻓﻲ ﺍﻟﺩﺭﺍﺴﺔ
  . ﺍﻟﻤﺼﺒﻭﻍ ﺒﺒﺭﻭﻤﻴﺩ ﺍﻻﻴﺜﻴﺩﻴﻭﻡ
 ﻋﻠﻰ ﺀ ﺘﻔﺎﻋل ﺍﻟﺒﻠﻤﺭﺓ ﺍﻟﻤﺘﺴﻠﺴل ﺍﻟﻌﻜﺴﻲﺘﻡ ﺇﻜﺜﺎﺭ ﺍﻟﻨﺎﺘﺞ ﻋﻨﺩ ﺇﺠﺭﺍﻟﻡ ﻴ, ﻓﻲ ﺍﺨﺘﺒﺎﺭﺍﺕ ﺍﻟﺨﺼﻭﺼﻴﺔ
ﺍﻟﺤﻤﺽ ﺍﻟﻨﻭﻭﻱ ﺍﻟﺭﻴﺒﻲ ﺍﻟﻤﺴﺘﺨﻠﺹ ﻤﻥ ﻓﻴﺭﻭﺱ ﺍﻟﻤﺭﺽ ﺍﻟﻨﺯﻓﻲ ﺍﻟﻭﺒﺎﺌﻲ ﺃﻭ ﻤﻥ ﻓﻴﺭﻭﺱ ﺒﺎﻟﻴﺎﻡ 
  . ﻤﻤﺎ ﻴﺩل ﻋﻠﻰ ﺍﻨﻪ ﺨﺎﺹ ﻓﻘﻁ ﺒﻔﻴﺭﻭﺱ ﺍﻟﻠﺴﺎﻥ ﺍﻷﺯﺭﻕ
ﺒﻲ ﻫﺫﺍ ﺍﻟﻨﺎﺘﺞ ﻓﺎﺌﻕ ﺍﻟﺨﺼﻭﺼﻴﺔ ﺘﻡ ﺇﻜﺜﺎﺭﻩ ﻤﻥ ﻜﻤﻴﺎﺕ ﻤﺨﺘﻠﻔﺔ ﻤﻥ ﺍﻟﺤﻤﺽ ﺍﻟﻨﻭﻭﻱ ﺍﻟﺭﻴ
 5.0,  ﻨﺎﻨﻭﺠﺭﺍﻡ0.1:  ﻟﻔﻴﺭﻭﺱ ﺍﻟﻠﺴﺎﻥ ﺍﻷﺯﺭﻕ  ﻭﻫﻲ2ﺍﻟﻤﺴﺘﺨﻠﺹ ﻤﻥ ﺍﻟﻨﻤﻁ ﺍﻟﻤﺼﻠﻲ 
ﺔ ﺘﻔﺎﻋل ﺍﻟﺒﻠﻤﺭﺓ ﺍﻟﻤﺘﺴﻠﺴل ﻤﻤﺎ ﻴﺅﻜﺩ ﺤﺴﺎﺴﻴ,  ﻨﺎﻨﻭﺠﺭﺍﻡ521.0 ﻨﺎﻨﻭﺠﺭﺍﻡ ﻭ 52.0, ﻨﺎﻨﻭﺠﺭﺍﻡ
  .  ﻓﻲ ﺍﻟﻜﺸﻑ ﻋﻥ ﻓﻴﺭﻭﺱ ﺍﻟﻠﺴﺎﻥ ﺍﻷﺯﺭﻕﺍﻟﻌﻜﺴﻲ
x 
 ﺒﺎﺴﺘﺨﺩﺍﻡ ﺍﻟﺒﺎﺩﺌﺎﺕ ل ﺍﻟﻌﻜﺴﻲﻠﺴﻓﺎﻥ ﻨﺘﺎﺌﺞ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺘﻭﻀﺢ ﺃﻥ ﺘﻔﺎﻋل ﺍﻟﺒﻠﻤﺭﺓ ﺍﻟﻤﺘﺴ, ﺨﺘﺎﻤﺎﹰ
ﺫﻭ ﺨﺼﻭﺼﻴﺔ ﻭ ﺤﺴﺎﺴﻴﺔ , ﺴﺭﻴﻊ,  ﺒﺴﻴﻁﺫﻜﻭﺭﺓ ﺃﻋﻼﻩ ﻴﻤﻜﻥ ﺍﺴﺘﺨﺩﺍﻤﻪ ﻜﺎﺨﺘﺒﺎﺭ ﺘﺸﺨﻴﺼﻲﺍﻟﻤ
  .ﻟﺩﻋﻡ ﺍﻟﻁﺭﻕ ﺍﻟﺘﻘﻠﻴﺩﻴﺔ ﺍﻟﻤﺴﺘﺨﺩﻤﺔ ﻓﻲ ﺘﺸﺨﻴﺹ ﻓﻴﺭﻭﺱ ﺍﻟﻠﺴﺎﻥ ﺍﻷﺯﺭﻕ 
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CHAPTER ONE 
Introduction and General Literature Review 
 
1.1. Introduction 
        Bluetongue (BT) is an infectious, non-contagious arthropod-borne 
disease of ruminants, caused by bluetongue virus and transmitted between 
vertebrate hosts via the bites of certain species of biting midges of the 
genus Culicoides (Mellor, 1990).  Bluetongue was first reported in the 
year 1881 as a result of the introduction of European breeds of sheep into 
southern Africa (Howell and Verwoerd, 1971). 
        The viral etiology of the disease was demonstrated in 1906 and its 
strains have been identified in many tropical and temperate areas of the 
world since that time. While the virus is classified antigenically and 
taxonomically as bluetongue virus, each serotype is unique and may not 
cause the disease (Callis, 1985).  
        Bluetongue virus (BTV) is a double stranded (ds) RNA orbivirus 
of the family Reoviridae (Borden et al., 1971; Fenner et al., 1974; Gould 
et al., 1992). BTV naturally infects domestic and wild ruminants, 
camelids and some other herbivores such as elephants, but it is almost 
exclusively a disease of sheep. In cattle and goats clinical disease is rare, 
and, when present, is much milder than in sheep (Verwoerd and Erasmus, 
 2
1994). Bluetongue disease was thought to be limited to sheep until 1933 
when the virus was isolated in South Africa from cattle with clinical signs 
similar to those of foot and mouth disease (Bekker et al., 1934).  
        The virus has a world wide distribution and it exists in at least 25 
serotypes (Davies et al., 1992). It occurs in the Americas, Africa, Asia 
and Australia, and it can cause an acute, sub-acute, mild or inapparent 
disease (Mellor and Wittmann, 2002). 
Serotypes 1, 2, 4 and 16 are enzootic in the Sudan, while serotypes 
2, 10, 11, 13 and 17 are enzootic in North America (Davies et al., 1992; 
Mohammed and Taylor, 1987).  
The mortality rate of bluetongue disease vary from 0% to 30%, but 
can reach 75% (Mellor et al., 1983) in highly susceptible animals, but 
that is dependent upon the serotype involved. The real significance of 
bluetongue disease lies in the indirect losses sustained; these include 
abortion in pregnant ewes and severe loss of condition during prolonged 
convalescence (Tomori et al., 1991). 
        It has been estimated that BTV alone causes losses to international 
livestock trade in excess of US$ 3 billion a year (Tabachnick et al., 
1996). Immunization of susceptible animals requires multivalent vaccines 
because bluetongue vaccines are serotype specific. 
Diagnostic tests currently used for the detection of BTV involve 
the isolation and growth of virus isolates in eggs or sheep, followed by 
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passaging in tissue culture. The virus is characterized using serological 
tests such as the agar gel immunodiffusion test or serum neutralization 
test. These procedures are time-consuming and may fail to detect low 
levels of virus. The use of enzyme-linked immuno-sorbent assay (ELISA) 
for the detection of antibodies of BTV in infected animals is faster but 
doesn’t confirm recent infection. These traditional methods may require 
at least three to four weeks to provide a result. The polymerase chain 
reaction technique may be used not only to detect the presence of BTV 
but also to serogroup the virus and provide information on the serotype 
within a few days (Zientara et al., 2004)    
The objective of the present study was to develop a simple, rapid, 
sensitive, specific and inexpensive method for detection of bluetongue 
virus serogroup using a reverse transcriptase (RT) polymerase chain 
reaction (RT-PCR). 
 
1.2. The bluetongue virus  
1.2.1. Virus classification 
Family: Reoviridae 
             Contains twelve genera of multi-segmented dsRNA viruses. 
Genus: Orbivirus 
The members of this genus called ‘orbiviruses’. They are twenty 
one species which characteristically have a ten segmented 
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dsRNA genome that is packaged within an icosahedral protein 
capsid.                                                                                                                     
Species: Bluetongue virus 
It is the prototype of twenty one different species of the genus 
Orbivirus. It has a capsid composed of three distinct protein 
layers: the subcore, the core-surface layer and the outer capsid 
layer (Mertens et al., 2004). 
 
1.2.2. Virus structure 
        Bluetongue virus is an icosahedral-shaped particle consisting of a 
segmented double-stranded RNA genome, encapsidated in a double-
layered protein coat. Removal of the outer protein layer activates a viral-
associated RNA polymerase which transcribes the ten genome segments 
into 10 mRNAs which are in turn translated into seven structural (VP1-
VP7) and three non-structural (NS1,NS2 and NS3) proteins (Huismans 
and van Dijk, 1990). The virus particle is arranged as three concentric 
capsid shells surrounding the viral dsRNA (Basak et al., 1997; Grimes et 
al., 1995; Huismans and van Dijk, 1990). The outermost layer (the outer 
capsid) is composed of two structural proteins, VP2 and VP5, which are 
principally involved in virus attachment and penetration of the host cell 
during the initiation of infection. These are the most variable of the viral 
proteins and the specificity of their interactions with neutralizing 
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antibodies (particularly those of VP2) determines virus serotype (Eaton et 
al, 1990; Huismans and van Dijk, 1990; Roy et al., 1990).VP2 is coded 
for by genome segment 2, and VP5 is coded for by genome segment 5 
(Verwoerd et al., 1970). 
        The two innermost protein shells that make up the transcriptionally 
active virus core, are composed of VP3 and VP7, respectively. These are 
more highly conserved proteins, showing serological cross reactions 
within the BTV species (Grimes et al., 1995; Mertens, 1999; Mertens et 
al., 1987; Verwoerd et al., 1972). VP3 is coded for by genome segment 3 
(Huismans and van Dijk, 1990), and VP7 is coded for by genome 
segment 7 (Huismans et al., 1987) 
  The non-structural proteins NS1, NS2 and NS3 are coded for by 
genome segments 6, 8 and 10, respectively (Roy, 1992).  
 
1.3. Vector and Transmission 
        Midges of the genus Culicoides act as biological vectors of 
bluetongue virus. Of the approximately 1400 species of Culicoides world-
wide, less than 20 are considered actual or possible vectors (OIE, 1998; 
Mellor, 1990).  
The most well-studied vector species are C. varipennis and C. 
insignis in the United States of America, C. fulvus, C. wadai, C. actoni 
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and C. brevitarsis in Australia, and C. imicola in Africa and the Middle 
East (Erasmus, 1990).   
        The insect vectors of BTV breed in moist conditions in a variety of 
habitats, particularly damp, muddy areas and in faecal and plant matter. 
They have nocturnal feeding habits, preferring still, warm conditions, 
pastures and open pens. 
Females take a blood meal prior to egg laying, feed at roughly 4-
day intervals and live for about 2 to 3 weeks. The eggs hatch in 2 to 3 
days, and, depending on the temperature, the larval stage lasts 12 to 16 
days. Adults emerge 2 to 3 days after pupation and take a blood meal 1 
day later and they also mate during this time (Roberts, 1990). The 
activities of the midge are influenced by temperature and the optimum 
lies between 13ºC and 35ºC (Sellers, 1981).  
        BTV has evolved a life cycle where alternate cycles of virus 
replication in vertebrate and invertebrate hosts are essential for virus 
persistence (Roberts, 1990). 
The midges may be infected when biting viraemic vertebrates. The 
chance of infection depends in part on the genotype of the midge, the 
strain of virus, the level of viraemia, and environmental factors. The 
incubation period (between feeding on infected blood and the appearance 
of virus in the saliva of the midge) is 1-2 weeks (Mellor et al., 2000). 
Viraemia must be of the order of 104 infectious units of virus per 1ml of 
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blood or greater for feeding midges to have much chance of infection. 
The peak levels of viraemia, in virus infectious units per 1ml of blood, 
were reported as 104.4 to 106.3 for cattle, 106.4 to 108 for sheep and 106 
for goats. Viraemia peaks in the first two weeks after infection, before the 
appearance of serum antibodies. Virus titres then drop rapidly and are 
very low if infection persists for a month or more (OIE, 1998). The 
duration of viraemia in the infected vertebrates is an important factor in 
the transmission of BTV to biting midges (Mac Lachlan, 1994). The 
duration of viraemia of most cattle is less than 4 weeks with less than 1% 
exceeding 8 weeks (OIE, 1998). The maximum viraemia reported for 
sheep is 54 days (Koumbati et al., 1999). Singer et al. (2001) analyzed a 
large volume of existing data on the length of bluetongue viraemia of 
cattle and concluded that this was equal to or less than 9 weeks in >99% 
of adults.  
There is no evidence of vertical transmission of the virus in the 
invertebrate hosts. Any vertical transmission in vertebrates is considered 
to be of no consequence to virus ecology because observations on the 
placental transmission of virus in the vertebrate hosts are contradictory 
(Roberts, 1990). There is a little evidence of direct or indirect contact 
transmission in either host, other than rare instances of seminal 
transmission in vertebrates (OIE, 1998). The virus can not be spread by 
meat, milk or dairy products (Erasmus, 1990). 
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1.4. Epidemiology and Distribution 
        Bluetongue is a common, generally sub-clinical infection of 
ruminants throughout the tropics and subtropics, within a number of 
separate ecosystems. Seasonal incursions of the virus into more temperate 
latitudes, sometimes accompanied by disease, may occur under favorable 
climatic conditions at certain key locations (Gibbs and Greiner, 1994). 
Bluetongue disease is the result of a complex interaction between the 
animal, the virus and the environment. It is almost exclusively a disease 
of sheep, with European breeds most susceptible. Most breeds of sheep, 
especially in regions where the virus is endemic, are resistant to disease 
though there is increasing information that native breeds in India and 
China can be clinically affected. Outbreaks of disease typically occur 
either when susceptible sheep are introduced to endemic areas, or when 
infected midges carry the virus from endemic regions to adjacent areas 
containing populations of immunologically-naive susceptible sheep 
(Erasmus, 1990).                                                       
        There is evidence that infected midges are carried on the wind for 
long distances (Sellers, 1981). It has been postulated that the major 
epidemics of bluetongue, in regions where disease occurs only 
sporadically can often be traced to windborne carriage of infected 
Culicoides from distant areas (Gibbs and Greiner, 1988).   
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Over the past 30 years, evidence of regular virus activity, but not 
necessarily disease, has been found in most countries in the tropics and 
subtropics with substantial populations of ruminants. The virus may be 
found in a geographic band between latitudes 40º N and 35º S. The 
presence of BTV within this band, whether year round or seasonal, 
depends on the climatic zone type. Genetic studies (topotyping) indicate 
that the virus existence in discrete, stable ecosystems, probably the result 
of co-evolution of different strains of virus and vectors (OIE, 1998). 
Numerous countries in the tropics and subtropics have bluetongue virus 
unknowingly circulating subclinically in cattle and other ruminants.  
A properly designed serological survey would reveal the presence 
of the virus. The virus is endemic in areas of some countries, being more 
or less continuously active. Depending on climatic factors affecting the 
vector, in most years the virus will seasonally extend to adjacent areas 
(Gibbs and Greiner, 1988).  
Many strains of bluetongue virus appear incapable of causing 
significant disease following natural or experimental infection of sheep 
known to be susceptible to disease. Experimental reproduction of disease 
can be inconsistent, except with the most virulent strains of virus. This 
could be because exposure of sunlight can have a marked influence on the 
severity of disease (Erasmus, 1990).  
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1.5. Bluetongue disease in Sudan 
 In Sudan, bluetongue disease was first reported in 1953 when 
samples from the Blue Nile Province were confirmed by the Veterinary 
Research Laboratory at Onderstepoort, South Africa, to contain 
bluetongue virus (Anon, 1953).  
 Infection of sheep with BTV at Khartoum University Farm, 
Shambat, was suspected on the basis of clinical symptoms but was not 
confirmed by virus isolation (Pillai, 1961).  
 Bluetongue virus group specific antibodies have been detected 
throughout the Sudan in the sera of many species of ruminants, which 
suggested a wide distribution of the virus. Although the high levels of 
bluetongue antibodies and antigens that have been found among cattle, 
sheep, goats and camels in Sudan, no virus isolation was made in earlier 
years (Eisa et al., 1979, 1983; Abu Elzein, 1983, 1985a, 1986; Abu 
Elzein et al., 1987; Herniman et al., 1980). 
An outbreak, from which BTV was isolated, involved indigenous 
sheep in Western Sudan. The stress which these animals have been 
exposed to while being driven over long distances enhanced the severity 
of the disease (Eisa et al., 1980). 
 An outbreak of bluetongue disease in 3-6 months old indigenous 
lambs was reported in Khartoum Province in 1982. The BTV was isolated 
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and the disease was experimentally induced (Abu Elzein and Tag Eldin, 
1985). 
 Bluetongue virus was suggested as the cause of death of a Frezian 
cross-herd calf at the Khartoum University Farm at Shambat, but the 
virus was not isolated (Mohamed et al., 1980).  
 BTV serotype 5 was isolated from Culicoides species in Sudan 
(Mellor et al., 1984).                                                  
 
1.6. Economic Importance 
        Bluetongue can be a costly infection for several reasons. The 
clinical disease in sheep can be severe, resulting in wool break, weight 
loss and death. In some countries where disease is endemic such as 
Sudan, South Africa and USA, vaccination is a recurring cost.  However, 
the greater cost of bluetongue is to infected countries which export live 
animals, germplasm and some animal products such as fetal calf serum. 
Here the presence of bluetongue virus, even if wholly sub clinical, causes 
loss of trade due to restriction on the source of animals, and the cost of 
health testing. It has been estimated that in the late 1970s, the ban on US 
cattle semen exports resulted in an annual loss of $24 million (Gibbs and 
Greiner, 1988). 
Bluetongue is included in the OIE list A diseases, largely because 
of dramatic outbreaks of disease in Cyprus in 1943 and Portugal and 
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Spain in 1956.  The Cyprus outbreak was due to a particularly virulent 
strain of the virus causing between 60-70% losses in some flocks 
(Gambles, 1949). Within the first 4 months, 46,000 sheep had died in 
Portugal and 133,000 in Spain (Roberts, 1990). This listing of bluetongue 
in the most serious list of animal diseases exacerbates the trade sensitivity 
and associated costs to countries with the infection (Gibbs and Greiner, 
1994). 
 
1.7. Pathology of bluetongue disease 
1.7.1. Pathogenesis of BTV 
        After introduction by the bite of an infected midge, bluetongue 
virus first replicates in the local lymph node and subsequently induces a 
primary viraemia which seeds other lymph nodes, spleen, lung and 
vascular endothelium (Gibbs and Greiner, 1988). Circulating virus 
associates with blood cells, mostly with erythrocytes and platelets, though 
virus associated with mononuclear cells is critical for dissemination of 
virus throughout the animal. Later in viraemia, the virus is exclusively 
associated with erythrocytes (Mac Lachlan, 1994). Virus particles appear 
to be sequestered in invaginations of the erythrocyte membrane, allowing 
prolonged viraemia in the presence of neutralizing antibodies (OIE, 
1998).  
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        All of the pathology of bluetongue can be assigned to vascular 
endothelial damage resulting in changes to capillary permeability and 
fragility, with subsequent disseminated intravascular coagulation and 
necrosis of tissues supplied by damaged capillaries. These changes result 
in oedema, congestion, hemorrhage, inflammation and necrosis (Erasmus, 
1990). 
 
1.7.2. Immune response to bluetongue virus 
 The mechanism of immunity to BTV infection, and whether this 
immunity is mediated by the humoral or the cellular components of the 
immune system, is not fully understood.  
 Evidence of  the role of cell-mediated immunity (CMI) in BTV 
infection has been demonstrated in sheep (Stott et al., 1979). Sheep which 
had been vaccinated with an inactivated BTV vaccine, were refractory to 
challenge with homologous virus in the absence of neutralizing 
antibodies. Bluetongue virus specific cytotoxic T-Lymphocytes (CTLs) 
have been induced in sheep (Jeggo et al., 1985) and their important role 
in clearing BTV in sheep was indicated (Ghalib et al., 1985). CTLs also 
have been induced in mice infected with live BTV (Jeggo and Wardley, 
1982). 
 The immune response to BTV infection in cattle is complex when 
compared to that of sheep. Whereas the appearance of neutralizing 
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antibodies in the serum of infected sheep coincides with a subsequent 
decline in circulating virus, this does not seem to be the case in cattle 
(Luedke et al., 1977). Even in the presence of high titre of neutralizing 
antibodies, the viraemia in cattle persists for months. The failure of cattle 
to display clinical disease in the face of prolonged viraemia suggests an 
impaired immune response (Osburn, 1985). Immunological tolerance and 
viral persistence have been reported in congenitally infected calves 
(Luedke, et al., 1977). Congenital infection has also been demonstrated in 
bovine fetuses infected between 85 and 125 days of age. The virus was 
not recovered from these calves at birth, but virus specific antibodies 
were detected in precolostral serum samples (Mac Lachlan et al., 1985). 
Clinical bluetongue disease in cattle is mediated by IgE  antibodies, and 
the role of CMI in bluetongue immunology in cattle is not fully 
understood (Jochim, 1985).              
 
1.7.3. Clinical signs   
        Fever is usual but not invariable. Other common clinical signs 
include oedema (of lips, nose, face, submandibulum, eyelids and 
sometimes ears), congestion (of mouth, nose, nasal cavity, conjunctiva, 
skin and coronary bands), lameness and depression. The oedema of lips 
and nose can give the sheep a ‘monkey-face’ appearance. There is 
frequently a serous nasal discharge, later becoming mucopurulent. The 
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congestion of the nose and nasal cavity produces a ‘sore muzzle’ effect, 
the term used to describe the disease seen in sheep in the USA before its 
bluetongue virus etiology was realized. The mouth is sore and the sheep 
may champ to produce a frothy oral discharge. Sheep are not strictly 
anorexic, but eat less because of oral soreness and will hold food in their 
mouths to soften it before chewing. Affected sheep occasionally have 
swollen, congested, cyanotic tongues. Lameness, due to coronary band 
congestion, may occur early in the disease, and lameness, as a result of 
skeletal muscle damage, may occur later.  
        If fever occurs, sheep are first pyretic 4-10 days after infection. The 
other clinical signs, soon followed with acute deaths, occurring during the 
second week following infection. Many of theses deaths are the result of 
pulmonary oedema and/or cardiac insufficiency. Further sheep may die 
from chronic disease 3 to 5 weeks after infection with bacterial 
complications, especially Pasteurellosis. The production loss due to 
bluetongue may be the result of deaths, unthriftiness during prolonged 
convalescence and possibly reproductive wastage (OIE, 1998). 
        Although the frequency of infection of cattle with BTV is generally 
higher than in sheep, disease in cattle is rare. Clinical infection is actually 
a hypersensitivity reaction including fever, stiffness or lameness and 
increased salivation. The skin of the muzzle is often inflamed, and may 
crack and peel. The lips and tongue may be swollen, with ulcers on the 
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oral mucosa. Similarly, the skin of the neck, flanks, perineum and teats 
may be affected (Erasmus, 1990).       
        Hydranencephaly and congenital deformities may develop in 
bovine and sheep fetuses of bluetongue virus-infected dams. The severity 
of lesions is depending on the stage of gestation. Fetuses seem to be most 
susceptible during the period of active brain development (Erasmus, 
1990). 
It is clear that cell culture-adapted virus more readily crosses the 
placenta than unadapted virus, suggesting that the occasionally instances 
of natural virus-induced teratogenesis may be due to strains of virus 
derived from live virus vaccines (Mac Lachlan, 1994).  
        Bluetongue in dogs associated with use of a contaminated vaccine 
was reported by Akita et al. (1994). Only pregnant bitches were affected.      
 
1.7.4. Post-mortem findings 
        In animals dying acutely, the oral mucosa is hyperemic and 
petechiae or ecchymoses may be present. Excoriations may be in areas 
subject to mechanical abrasion; the edges of lips, dental pad, tongue and 
cheeks opposite to molar teeth. There may be hyperemia in the fore-
stomach. The lungs may be hyperemic with severe alveolar and 
interstitial oedema, froth in the bronchi, and excess fluids in the thoracic 
cavity. The pericardial sac may have petechiae and excess fluids.  
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A variable sized hemorrhage in the tunica media near the base of 
pulmonary artery is almost pathognomonic. Sub-epicardial and sub-
endothelial hemorrhages, particularly those involving the left ventricle 
are common. Generalized damage to the cardiovascular system is 
evidenced by widespread hyperemia, oedema and hemorrhage (Erasmus, 
1990).  
        Animals that die later than 14 days after infection often show 
dramatic degeneration and necrosis of the skeletal musculature. Muscles 
lose pigmentation and the inter-muscular fasciae are infiltrated with clear 
gelatinous fluids (Erasmus, 1990). 
Microscopic examination of mucosal lesions shows mononuclear 
cells infiltration, degeneration and necrosis of epithelial cells in which 
large acidophilic intra-cytoplasmic masses accumulate. Affected muscles 
have oedema, hemorrhage, hyaline degeneration and necrosis. Infiltration 
by neutrophils, macrophages and lymphocytes is present in acute cases 
(Verwoerd and Erasmus, 1994).  
 
1.8. Diagnosis of BTV  
1.8.1. Virus Isolation 
        A number of methods for the isolation of bluetongue virus have 
been developed over the past fifty years in an attempt to increase the 
efficiency with which virus in field materials can be amplified to 
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facilitate identification. Favored methods include replication in 
embryonated chicken eggs (ECE), sheep, and a wide variety of cultured 
cells (Clavigo et al., 2000; Gard et al., 1988; Gard et al., 1992; Gould et 
al., 1989; Wechsler and McHolland, 1988). 
 
1.8.1.1. Embryonated Chicken Eggs (ECE) 
       Mason, Coles and Alexander (1940) first reported the growth of BTV 
in chicken embryos following inoculation into the yolk sac of ECE 
(Mason et al., 1940). Over a quarter of a century later, Goldsmit and 
Barzilai (Goldsmit and Barzilai, 1968) and Foster and Luedke (Foster et 
al., 1972) showed that intravenous inoculation of ECE was 100-1000 
times more sensitive than yolk sac administration. Since then, intravenous 
inoculation of 10-13-day-old ECE has been widely used as the method of 
choice in the isolation of BTV from clinical samples (Clavigo et al., 
2000). The preferred tissues for isolation include washed, unseparated 
blood cells, spleen, lung and lymph nodes (Pearson et al., 1992). 
Preparation of washed blood cells for inoculation into ECE is 
straightforward, whereas tissues must be homogenized by grinding with 
sand in a mortar and pestle or in tissue grinder. The number of ECE 
inoculated per sample varies but is usually 10, the incubation temperature 
33-34ºC and the inoculum dose 0.01ml. Although dead embryos are 
usually the source of virus for identification, embryo deaths are neither an 
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indication of BTV replication nor are surviving embryos indicative of 
virus absence (Eaton and White, 2004).  
 
1.8.1.2. Sheep inoculation 
        Sheep have been variously described to be as efficient as ECE 
(Foster et al., 1972; Goldsmit et al., 1975), less efficient than ECE 
(Breckon et al., 1980) and more efficient than ECE (Luedke, 1969; 
Parsonson et al., 1981). The latter suggested that the larger sample 
volume that can be administered to sheep might account for the enhanced 
efficiency of isolation compared with ECE. However, sheep inoculation 
is often an impracticable option because of the requirement to maintain 
the sheep for at least 30 days after inoculation to permit development of 
the antibody response that provide evidence of virus infection (Eaton and 
White, 2004).  
 
1.8.1.3. Cultured cells 
        The first successful attempt to grow BTV in cultured cells was in 
1956. BTV adapted for growth in eggs by serial passage in ECE was 
shown to replicate in primary lamb kidneys (Haig et al., 1956). The first 
successful isolation in tissue culture of wild-type non-egg adapted virus 
from the blood of infected sheep was in 1959 (Fernandes, 1959). Shortly 
 20
thereafter, direct isolation of BTV in cultured cells was confirmed 
(Livingston and Moore, 1962; Pini et al., 1966). 
Among the large number of mammalian cell lines that have been 
evaluated for their sensitivity to BTV, baby hamster kidney (BHK), 
African green monkey (Vero) and calf pulmonary artery endothelium 
(CPAE) are most frequently used (Pearson et al., 1992). 
 
1.8.2. Virus Identification 
        Identification of BTV is an essential part of the laboratory 
confirmation of BTV infection. This may be achieved in three different 
ways: 
a. Identification of antibodies by serological assay 
b. Identification of the virus antigens by virological assay 
c. Identification of the specific nucleic acids of BTV by reverse 
transcriptase-polymerase chain reaction (RT-PCR) and sequence 
analysis (Zientara et al., 2004). 
   
1.8.2.1. Serological techniques 
        The outer capsid, structural viral proteins VP2 and VP5 of BTV are 
the serotype determinants and are responsible for generation of serotype-
specific neutralizing antibodies (Roy et al., 1990). 
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       Testing sera for the presence of BTV antibodies may be required for 
serotype identification of field strains, for monitoring vaccination 
campaigns, for serological surveillance, and to facilitate safe international 
trade in live animals, animal products and germplasm (Hamblin, 2004). 
        Two prescribed tests were outlined by the OIE Manual (OIE, 2000) 
for international trade, namely, the agar gel immunodiffusion (AGID) 
(Pearson et al., 1979) and competitive enzyme-linked immunosorbent 
assay (c-ELISA) (Jeggo et al., 1992).  
 
1.8.2.1.1. Agar gel immunodiffusion (AGID)    
        The AGID test (Pearson et al., 1979) is well documented as a 
serogroup-specific test for the detection of BTV antibodies. Although the 
AGID test may still be used in some laboratories, the lack of sensitivity 
(Gustafson et al., 1992; Pearson, et al., 1992) and documented cross-
reactions that can occur with other orbivirus serogroups (Pearson, et al., 
1992) makes the continued use of this assay questionable when more 
rapid, sensitive and specific tests are readily available. 
 
1.8.2.1.2. Competitive enzyme-linked immunosorbent assay  
                (c-ELISA) 
        The ELISA has been used for approximately 40 years (Voller et 
al., 1979) and has provided a valuable means of studying numerous 
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antigens and their antibodies. ELISA is a serogroup-specific test, 
identifying primarily the highly conserved BTV VP7 of all known 
serotypes. Using the c-ELISA as a spot test will only provide a qualitative 
measurement of positivity (Hamblin, 2004). 
Competitive ELISA (cELISA) is probably the most widely used 
and validated method (Jeggo et al., 1992). 
 
1.8.2.2. Virological techniques 
        Several virus/ antibody-based methodologies for the identification 
of BTV have been described and they fall into two categories, being 
either serogroup-specific such as ELISA, or serotype-specific such as 
virus neutralization test (Hamblin, 2004). 
 
1.8.2.2.1. Virus neutralization test 
        It is a serotype-specific test which can be used to identify all 
antigenically distinct serotypes of BTV. The sensitivity of this assay is 
dependent on the titer of virus in the test sample (Hamblin, 2004). 
 
1.8.2.3. Reverse transcriptase-polymerase chain reaction (RT-PCR) 
        The PCR is a method for in vitro amplification of DNA. It is a 
series of multiple rounds of primer extension reactions in which 
complementary strands of a defined region of a DNA molecule are 
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simultaneously synthesized by a thermo stable DNA polymerase 
(Zientara, et al., 2004). 
        This primer-directed amplification of viral nucleic acid has 
revolutionized BT diagnosis. Results to date indicate that PCR technique 
may be used, not only to detect the presence of viral nucleic acid, but also 
to ‘serogroup’ orbiviruses and provide information on the serotype and 
possible geographic source of BTV isolates within a few days of receipt 
of a clinical sample, such as infected sheep blood. 
        Oligonucleotide primers used to date have been derived from 
RNA7 (VP7 gene), RNA6 (NS1 gene), RNA3 (VP3 gene) and RNA2 
(VP2 gene). 
        The PCR assay involves three separate procedures. In the first, 
BTV RNA is extracted. The second procedure is the denaturation of viral 
ds-RNA and reverse transcription (RT) to generate DNA, which is 
amplified by PCR. The final step of the process is the analysis of the PCR 
product by electrophoresis (OIE, 2000; Dadhich, 2004).  
 
1.9. Prevention and control 
Bluetongue is a disease of sheep, but cattle are the principal 
vertebrate reservoirs of the virus. Once established, it is impossible to 
actively eradicate bluetongue virus. The virus will circulate, generally sub 
clinically, in cattle and other ruminants, and in midges. In countries 
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marginally suitable for virus persistence, the virus may be maintained for 
several years before dying out (Roberts, 1990). 
In seasonally infected areas, the onset of cold weather will reduce 
midge populations to ineffective levels and cause the virus to retreat to 
regions of year-round activity.  
        The bluetongue virus cycle could be interrupted by the 
immunization of vertebrate hosts, especially cattle, removal of vectors, or 
prevention of vector attack. Understandably, the immunization of animals 
that will not suffer from the disease is not acceptable to farmers. The 
control of midges by the application of insecticides and larvicides to 
insect resting and breeding sites, or systemically to cattle, has not been 
fully investigated but is likely to have local success only. Protecting 
sheep from exposure to midges is a more practical approach and can be 
achieved by moving sheep from insect resting and breeding sites, stabling 
animals overnight, or the use of insect repellents. Mixing cattle with 
sheep will draw vectors with a host preference for cattle from sheep, but 
may raise the virus infection level of the midge population. Prophylactic 
immunization of sheep is the most practical and effective control 
measure, especially when the threat is from an epidemic due to a single 
serotype.  Multiple serotypes of virus are usual in endemic situations 
(Hawkes, 1996), requiring multivalent vaccines because bluetongue 
vaccines are serotype specific.  
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 The first method of immunization against bluetongue developed 
around 1900 in South Africa with inoculation of immune serum and 
infective blood. The attenuation of a strain of virus was achieved after 
limited serial passages in sheep. This was referred to as Theiler's vaccine, 
and over a period of 40 years more than 50 million doses were used. This 
vaccine was inadequate because of the plurality of virus strains occurring 
in nature (Howell and Verwoerd, 1971). The use of embryonated chicken 
egg-attenuated BTV in the production of polyvalent vaccine for sheep 
was found to be effective and the virus did not regain its virulence 
(Alexander and Haig, 1951; McKercher et al., 1957). 
However, multivalent vaccines have attendant problems resulting 
from interference between virus strains, differences in immunogenicity 
and growth rates between various strains, as well as differences in the 
response of individual animals to the components of such vaccines 
(Verwoerd and Erasmus, 1994). 
Additionally, there is growing concern by some scientists about the 
use of live attenuated bluetongue vaccines. Murray and Eaton (1996) 
summarized these concerns into four areas. These areas are: the known 
teratogenicity of attenuated virus for the developing fetus; the propensity 
for vaccine virus to be excreted in the semen of bulls and rams; the 
possibility that vaccine virus will infect vectors and establish in the 
environment; and the generation of recombinant progeny virus with novel 
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genetic and biological properties after the reassortment of genes from 
wild and vaccine virus in the vaccinated animal or the vector.  
        Alternatives to live attenuated vaccines are described by Murray 
and Eaton (1996). Vaccines based on inactivated whole virus, 
recombinant virus-like particles or recombinant core-like particles all 
show promise, but require more research. If a commercial product of any 
of these achieved, it will likely cost considerably more than a live 
attenuated vaccine. 
        Live attenuated bluetongue vaccines have wide use in South 
Africa, and more limited use in USA and a few other countries. The 
vaccines are compromises between attenuation and immunogenicity and 
may have residual pathogenicity for some vaccinated sheep. The 
application of the vaccines has to be well managed. Colostral immunity in 
young sheep can interfere with the development of active immunity to the 
vaccine, and breeding ewes and rams should be vaccinated before mating. 
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CHAPTER TWO 
Materials and Methods 
 
2.1. Bluetongue virus  
       The North American Bluetongue virus prototypes serotypes 2, 10, 11 
and 13 were obtained from Arthropod-Borne Animal Disease Research 
Laboratory, Laramie, WY.  The Sudanese isolates of BTV serotypes were 
recovered from Khartoum University farm at Shambat (Mohammed and 
Mellor; 1990).  
 
2.2. Virus propagation in tissue culture 
       Vero cells were cultured in 25 ml tissue culture flasks containing 
minimal essential medium (MEM).  Fetal Bovine Serum (FBS) was used 
at a concentration of 10% for growth and maintenance of cells, and they 
were incubated at 37 ºC for 2-3 days.  All viruses were propagated on 
confluent monolayers of Vero cells. The infectious materials were 
harvested When 80 % cytopathic effect (CPE) was observed (Usually 3-5 
days after infection).  The virus-infected cell culture was then kept at 4ºC 
till used for the dsRNA extraction.    
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2.3. Viral nucleic acid extraction from infected cell monolayers  
       Viral nucleic acid was extracted by the QIAamp viral RNA 
extraction kit following the mini spin protocol (QIAGEN GmbH, Hilden, 
Germany).  The carrier RNA was dissolved in 1ml AVL buffer and 
transferred to the AVL bottle and mixed thoroughly. 560 microlitre (µl) 
from this preparation were dispensed in each 1.5ml micro-centrifuge tube 
and kept at 4ºC.  All samples and reagents were equilibrated to room 
temperature (about 25ºC). 140 µl from the infected cell culture were 
added to the Buffer AVL/Carrier RNA in the micro-centrifuge tube, and 
mixed by pulse-vortexing for 15 seconds. The mixture incubated at room 
temperature (25ºC) for 10 minutes.  The tube was briefly centrifuged to 
remove drops from inside of the lid.  560 µl of ethanol (100%) were 
added and mixed by pulse vortexing for 15 seconds followed by brief 
centrifugation.  630 µl from the mixture were applied to the QIAamp spin 
column (in a 2ml collection tube) and centrifuged at 8000 rpm for 1 
minute.  The column was placed into a clean 2ml collection tube, the 
remaining 630 µl of the mixture were applied to it and the previous 
centrifugation step was repeated.  500 µl of buffer AW1 were added to 
the column, after placing it into a clean 2ml collection tube, and 
centrifuged at 8000 rpm for 1 minute.  500 µl of wash buffer AW2 were 
added to the column, after placing it into a clean 2ml collection tube, and 
centrifuged at 14000 rpm for 3 minutes.  The spin column was placed into 
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1.5ml micro-centrifuge tube and 60 µl of Buffer AVE were added. After 
it had been left at room temperature for 1 minute, the micro-centrifuge 
tube was centrifuged at 8000 rpm for 1 minute.  Finally the micro-
centrifuge tubes containing RNA extracts were labeled and kept at -20ºC 
till used in RT-PCR. The dsRNA concentration was determined by 
spectrophotometer at 260 nm wave length . 
 
2.4. Primers selection 
       Primers (P1 and P2) were selected from the published sequence of 
genome segment 6, which codes for non structural protein 1 (NS1) of 
BTV-17 (Hwang et al., 1993).  P1 included bases 648-667 of the positive 
sense strand of genome segment 6: 5´-GCC CTT ACA CTG GAT ACA 
GA-3´. P2 was designed from the complementary strand of the above 
sequence between bases 1242-1261: 5´-CCT CGC TCC AGT GTA ACA 
AT-3´. PCR amplification using P1 and P2 would be expected to produce 
a 614 base pair (bp) PCR product. 
Primers were synthesized on a DNA synthesizer (Milligen 
iosearch/Millipore, Burlington, MA) and purified using Oligo-Pak oligo-
nucleotide purification columns (Glen Research, Sterling, VA) as per 
manufacturer’s instructions.  
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2.5. Reverse transcriptase polymerase chain reaction (RT-PCR) 
        For each PCR amplification, 1.0 µl methyl mercuric hydroxide of 
80 mM concentration was used to denature a mixture of 5 µl of viral 
RNA and 2 µl of primers (P1 and P2).  The primers were used at a 
concentration of 20µg/µl. The mixture was then incubated at 25ºC for 10 
minutes. The mixture was neutralized by 10 µl of neutralizing solution 
containing 1 µl of β-mercapto ethanol, 8 µl of dNTPs (2 µl of each dATP, 
dTTP, dGTP and dCTP) and 1 µl of enzyme RNAse inhibitor. 
A reverse transcription step was performed to synthesize a 
complementary DNA (cDNA) from RNA templates using a reverse 
transcriptase mixture composed of 2.7 µl of 10X PCR buffer, 5 µl MgCl2 
of 1.5 mM concentration and 1.1 µl of the enzyme reverse transcriptase. 
8.8 µl of the reverse transcriptase mixture was added to each PCR tube. 
The PCR tubes were placed in the thermal cycler at 40ºC for 30 minutes. 
        For amplification, a mixture of 7.3 µl of 10X PCR buffer, 8 µl of 
MgCl2 and 1 µl of Taq DNA polymerase at a concentration of 5 units/µl 
was added to each PCR tube. The total volume of the PCR mixture was 
brought to 100 µl using double distilled water. 
        The RT-PCR was performed in (TECHNE, TC-412, USA) thermal 
cycler (figure 2.1) following a program of  a 2 minute incubation at 95ºC, 
followed by 40 cycles of (95ºC for 1 minute as denaturing temperature; 
56 ºC for 30 seconds  as annealing temperature and 72 º C for 45 seconds 
 31
for extension of  the predicted amplified PCR product).  A final 
incubation at 60ºC for 5 minutes was performed to complete the 
extension of uncompleted fragments of the PCR products. 
 
2.6. Agarose gel electrophoresis  
Following RT-PCR assay, the amplified products of cDNA 
transcribed from viral RNA molecules by RT-PCR were analyzed in 
agarose gel (SeaKem, agarose FMC Bioproducts, Rockland, ME).  1% 
agarose gel was prepared by suspending 1 gram of agarose powder in 
100ml of 1X Tris-boric acid-EDTA (TBE) buffer. The suspension was 
placed in the microwave for 2 minutes until the agarose was completely 
melted. Then 35ml of melted agarose was cooled and poured in the gel 
tray loaded with a comb. 
The agarose gel was submerged in the buffer basin of the 
electrophoresis apparatus (figure 2.2) filled with 1X TBE buffer 
containing 10 µl/500 ml ethidium bromide. 
To prepare 10X TBE buffer, 108 gram of Tris- (hydromethyl)- 
aminomethane, 55 gram of Boric acid and 7.4 gram of EDTA were mixed 
and brought to 1 litre using double distilled water. The buffer was kept at 
room temperature and used at 1x concentration for gel preparation and 
electrophoresis.     
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Per each electrophoresis run, 5 µl of 100 bp ladder molecular 
weight marker (MW marker) stained with an indicator dye was placed in 
the first lane of the gel. 12 µl of each RT-PCR product were loaded in the 
gel after being stained with 3 µl of an indicator dye (Bromophenol blue).  
Constant electric current of 90 mV then switched on for about 40 
minutes to allow the migration of the amplified PCR products. The 
standard molecular weight marker (1KB) was incorporated in each 
reaction for determination of the size of the amplified product by 
comparing this size with the separate distinguishable bands of the MW 
marker which were seen when the gel was stained with ethidium bromide. 
The gel was then visualized under UV light using gel 
documentation apparatus (figure 2.3). 
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Figure 2.1: Thermal cycler (TECHNE, TC-412, USA)  
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Figure 2.2: Electrophoresis apparatus 
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Figure 2.3: Gel documentation apparatus 
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CHAPTER THREE 
Results 
 
The BTV RT-PCR assay was a simple procedure that efficiently 
detected all BTV serotypes used in this study.  
 The described RT-PCR assay, with primers derived from genome 
segment 6 of BTV serotype 17, afforded sensitive and specific detection 
of all BTV serotypes used in this study. The specific 614 bp PCR product 
was visualized on ethidium bromide-stained agarose gel from 1ng RNA 
of North American BTV serotypes 2, 10, 11, and 13, and from 1ng RNA 
of Sudanese BTV serotype 2 (Figure 3.1). 
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Figure 3.1: Detection of BTV serotypes in infected cell cultures.  
Visualization of the 614 bp PCR product on ethidium bromide-stained 
agarose gel from 1ng RNA of North American BTV serotypes 2, 10, 11, 
and 13; and Sudanese serotype 2. Lane MW: molecular weight marker; 
Lane 2: North American BTV-2; Lane 2: Sudanese BTV-2; Lane 3: 
North American BTV-10; Lane 4: North American BTV-11; Lane 5: 
North American BTV-13.  Lane 6: Non-infected Vero cell (negative 
control). 
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Specificity of BTV RT-PCR 
 The specificity studies indicated that the specific 614 bp PCR 
product was not detected from 1ng of RNA from epizootic hemorrhagic 
disease virus (EHDV) serotype 1 and 1ng of RNA from Palyam virus 
(Figure 3.2). 
 
 
 
Figure 3.2: Specificity of RT-PCR for BTV.  
614 bp Amplification product was not detected from 1ng RNA of EHDV-
1 and Palyam virus. Lane MW: molecular weight marker; Lane 1: 
Sudanese BTV-2 (positive control); Lane 2: EHDV-1; Lane 3: Palyam 
virus. 
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Sensitivity of BTV RT-PCR 
 The sensitivity studies indicated that the specific 614 bp PCR 
product was obtained from the amounts of 1ng, 500 pg, 250 pg and 125 
pg RNA from Sudanese BTV serotype 2 (Figure 3.3).  
    
 
 
Figure 3.3: Sensitivity of RT-PCR for BTV.  
The specific 614 bp PCR product was obtained from the amounts of 1.0 
ng, 500 pg, 250 pg and 125 pg RNA from Sudanese BTV serotype 2. 
Lane MW: molecular weight marker; Lanes 1-4: (Sudanese BTV-2) 1.0 
ng, 500 pg, 250 pg and 125 pg, respectively.   
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CHAPTER FOUR 
Discussion 
 
Bluetongue virus is a serious veterinary problem (Shope et al., 
1960), and the economic importance of the disease is mainly attributed to 
clinical disease in sheep (Holf and Trainer, 1974; Pini, 1976; Jessup, 
1985). There is restriction on the international trade of livestock and 
animals products unless the animals are certified BTV-free by 
conventional virus isolation and serology (Osburn et al., 1994). Thus the 
disease is of interest to dairy producers and wildlife managers.   
Rapid detection of BTV is important in disease outbreaks as well 
as for determining disease-free status of exporting animals. Many 
diagnostic tests have been developed for detection of BTV including 
antibody, antigen and nucleic acid detection techniques (Mecham and 
Wilson, 1994). Antibody detection indicates that an animal has been 
previously exposed to the virus but not necessarily an indicator of 
viraemia. An indirect enzyme-linked immunosorbent assay (ELISA) and 
a competitive (C) ELISA, using a group-specific monoclonal antibody 
against bluetongue virus (BTV), are described for the detection of 
antibodies to BTV in cattle and sheep sera (Afshar et al., 1987). 
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 Antigen and nucleic acid detection assays are more indicative of 
viraemia, but can detect residual non-infectious molecules from a recent 
infection. None of the available antigen or nucleic acid detection assays 
have been validated for all the 25 serotypes of BTV.  Although antigen 
detection assays are very sensitive, inexpensive and reliable, they take 
long time to perform.  In addition, reagents are more difficult to develop 
than nucleic acid detection tests. Therefore, the development of a nucleic 
acid  amplification-based assay for all serotypes of BTV was necessary 
(Aradaib et al., 1998; Dangler et al., 1990; Katz et al., 1993; Shad et al., 
1997; Wilson and Chase, 1993). 
Conventional virus isolation and serology are time consuming and 
laborious (Pearson et al., 1992). The traditional approaches that rely on 
virus isolation followed by virus identification may require at least three 
to four weeks to generate information on BTV serogroup and serotypes.  
Also, conventional virus isolation may not provide data on the possible 
geographic origin of the isolates (Zientara et al., 2004). So, the 
development of molecular diagnostic techniques for detection of BTV 
would be advantageous in a variety of circumstances including clinical 
and sub clinical disease investigation, vaccination programs and 
epidemiological studies (Pearson et al., 1992; Aradaib et al., 1994, 1995). 
RT-PCR based detection assays have been described for detection 
of bluetongue virus infection in susceptible ruminants (McColl and 
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Gould, 1991; Wade-Evans et al., 1991; Wilson and Chase, 1993). BTV 
RT-PCR can provide rapid, sensitive and specific viral identification for 
BTV infections (Zientara et al., 2004). The primary gene target for group-
specific amplification was genome segment 6, which codes for non-
structural protein 1 (NS1) as it is highly conserved among cognate genes 
of BTV serogroup (Jensen and Wilson, 1995). 
The BTV RT-PCR assay was a simple procedure that efficiently 
detected all BTV isolates used in this study. The described RT-PCR assay 
specifically detected BTV RNA in infected vero cell cultures. Selection 
of the primers was based on the observation that NS1 gene of BTV is the 
most conserved among cognate genes of BTV serogroup (Aradaib et al., 
1998).  
The specific 614 bp PCR products, visualized on ethidium 
bromide-stained agarose gel, were obtained from all BTV RNA samples 
tested (1.0 ng each). The specificity studies indicated that the specific 614 
bp PCR product was not amplified from 1.0 ng of RNA from epizootic 
hemorrhagic disease virus (EHDV)-1 and RNA from Palyam virus under 
the same stringency condition described in this study. This confirmed that 
BTV NS1 genome is highly conserved among cognate genes of BTV 
serogroup.  
A nested PCR assay using primers derived from the non structural 
protein 1 (NS1) gene of North American BTV serotype 11  was 
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developed to detect the United States BTV serotypes 2, 10, 11, 13 and 17 
and the Sudanese BTV serotypes 1, 2, 4 and 16 and BTV serotype 4 from 
South Africa and BTV serotype 2 from Senegal. The primary specific 790 
bp PCR products and the nested 520 bp amplification products were not 
detected from closely related Orbiviruses including, EHDV serotypes 1, 
2, 4; Sudanese isolate of Palyam virus and total nucleic acid extracts from 
uninfected Vero cells (Aradaib et al., 2005).  
A duplex, one-step RT-PCR assay was developed and evaluated to 
detect genome segment 7 from any of the BTV serotypes. Assay 
sensitivity was evaluated using tissue culture derived virus, infected 
vector insects and clinical samples (blood and other tissues). No cross-
reactions were detected with members of closely related Orbivirus 
species (African horse sickness virus, Epizootic hemorrhagic disease 
virus and Palyam virus) (Anthony et al., 2007).   
Two new Real Time qPCRs were developed and validated to detect 
and amplify BTV segments 1 and 5 from all of the BTV serotypes. These 
two methods are complementary and could be used in parallel to confirm 
the diagnosis of a possible incursion of BTV (Toussaint et al., 2006). 
A new rapid single step RT-PCR with infra red (IR)-dye- labeled 
primers was reported as a sensitive and specific assay for detecting BTV 
RNA in Culicoides biting midges. All serotypes of BTV and none of the 
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eight serotypes of the closely related EHDV were detected (Kato and 
Mayer, 2006). 
The sensitivity studies indicated that the specific 614 bp PCR 
product was obtained from the amounts of 1 ng, 500 pg, 250 pg and 125 
pg RNA from Sudanese BTV serotype 2. Thus, in the present study, the 
described BTV RT-PCR protocol indicated that the PCR assay was 
capable of detecting the amount of 125 pg of BTV genomic dsRNA. 
However, the interpretation of positive BTV PCR results must be 
analyzed carefully, particularly in BTV-free areas before officially 
reporting BTV cases. In the absence of epidemiological data, virus 
isolation is strongly recommended to confirm molecular diagnosis 
(Zientara et al., 2004). 
The BTV RT-PCR assay provides supportive diagnostic technique 
to the lengthy cumbersome conventional virus isolation procedures. 
While the nested PCR assay required 7 hours for submission of the final 
results (Aradaib et al., 2005), the BTV RT-PCR assay described in this 
study, required 4 hours to obtain the final results. 
  The rapidity, sensitivity and specificity of the RT-PCR assay 
would greatly facilitate detection of BTV infection among susceptible 
ruminants. 
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In conclusion, the described BTV RT-PCR assay, using primers 
derived from genome segment 6 of BTV-17, provides a simple, rapid, 
specific and sensitive diagnostic method for detection of BTV. 
In addition, the PCR assay could be used for detection of the virus 
in areas of endemicity or incursion of the virus in BTV- free zones.  
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